I-CytoSorbents Corporation imemezele ukuthi Inkampani izobamba iqhaza kwi-10th EuroELSO Congress (EuroELSO 2022) e-London, e-UK ezoba ngoMeyi 4-6, 2022, enye yezingqungquthela ezimbili ezinkulu zabasebenzisi be-ECMO (extracorporeal membrane oxygenation) emhlabeni jikelele. I-CytoSorbents igqamisa isu "lokuphumula kwamaphaphu okuthuthukisiwe" kusetshenziswa i-CytoSorb ene-ECMO ukusiza ukwelapha i-acute Respiratory Distress Syndrome (ARDS) kanye nokwehluleka kwamaphaphu - zombili izimbangela ezinkulu zokufa ezigulini zase-ICU.
Idatha emisha yomtholampilo evela ezigulini ezingama-56 ezigula kakhulu ze-COVID-19 ezinokwehluleka ukuphefumula okungapheli ekusekelweni kwempilo nge-ECMO futhi zelashwe nge-CytoSorb ngaphansi kwe-FDA Emergency Use Authorization (EUA) evela ku-US CTC Registry izokwethulwa ngoLwesine, Meyi 5, 2022, endaweni isethulo esingacacile esinesihloko esithi: Ukusetshenziswa kwe-ECMO nge-Adjunctive Hemoadsorption Therapy ezigulini ze-COVID-19: Ukuhlaziywa Kokuqaphela okuvela ku-CytoSorb Therapy ku-COVID-19 (CTC) Registry. Lokhu kuhlaziya okusha kusekela ukubaluleka kokungenelela kusenesikhathi nge-CytoSorb kanye ne-ECMO ekwelapheni iziguli ezine-COVID-ARDS ehlobene ne-COVID, kanye neqhaza elingase libe khona ekusindeni okuphezulu kweziguli ezingama-52 ekuhlaziyweni kwangaphambili kwerejista, eshicilelwe kujenali ebuyekezwe ngontanga, I-Frontiers in Medicine, ngonyaka odlule.
I-CytoSorbents ingumxhasi weplatinamu weCongress futhi izophinde isingathe uchungechunge lwezemfundo oluzosakazwa bukhoma kuwebhusayithi ye-EuroELSO, enesihloko esithi “ECMO plus CytoSorb - Are We Doing It Right?” ngoLwesine, Meyi 5, 2022, kusukela ngo-12:45-1:45 PM CET ekamelweni lase-St. James.
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- Lokhu kuhlaziya okusha kusekela ukubaluleka kokungenelela kusenesikhathi nge-CytoSorb kanye ne-ECMO ekwelapheni iziguli ezine-COVID-ARDS ehlobene ne-COVID, kanye nendima yayo engaba khona ekusindeni okuphezulu kweziguli ezingama-52 ekuhlaziyweni kwangaphambili kwerejista, eshicilelwe kujenali ebuyekezwe ngontanga, I-Frontiers in Medicine, ngonyaka odlule.
- I-CytoSorbents ingumxhasi weplatinamu weCongress futhi izophinde isingathe uchungechunge lwezemfundo oluzosakazwa bukhoma kuwebhusayithi ye-EuroELSO, enesihloko esithi “ECMO plus CytoSorb – Are We Doing It Right.
- Idatha emisha yomtholampilo evela ezigulini ezingama-56 ezigula kakhulu ze-COVID-19 ezinokwehluleka ukuphefumula okungapheli ekusekelweni kwempilo nge-ECMO futhi zelashwe nge-CytoSorb ngaphansi kwe-FDA Emergency Use Authorization (EUA) evela e-U.